Viavi After the AI Lift: Tactical Long But Valuation Is Priced In

Hook / Thesis

Viavi Solutions has become one of the clearest beneficiaries of the AI infrastructure build-out. Recent results show revenue acceleration driven by data-center optical spending: revenue jumped 52.5% to $443.1 million in fiscal Q4 2026 and adjusted EPS rose to $0.34, with management guiding the next quarter to $450-460 million and non-GAAP EPS of $0.40-0.42. That kind of topline momentum has re-rated the stock, lifting market cap into the neighborhood of $8.3 billion.

That re-rating is the key tension here. Growth has gone from recovering to explosive in a matter of quarters, but multiples are no longer cheap. At $33.67 a share the company looks like a momentum growth story priced for near-perfection. For traders that means an actionable long that respects both upside from continued AI optical demand and the risk that the premium multiple will compress if execution or end-market spending slips.

What the company does and why the market cares

Viavi supplies test, monitoring and assurance tools for communications providers, data centers and network equipment manufacturers, and it sells optical and specialty products into aerospace, automotive and anti-counterfeiting markets. The Network and Service Enablement business now derives roughly half of its revenue from AI data-center work, according to commentary accompanying the latest results. In short: Viavi sits squarely on the optical connectivity stack that underpins AI infrastructure.

The market cares because optical networks are a bottleneck for AI scale. When hyperscalers and cloud providers expand capacity, vendors like Viavi get orders for test and monitoring gear plus optical modules tied to new deployments. We already see this reflected in peers: optical demand is lifting revenue across the segment and pushing backlog and guidance higher. Viavi’s Q4 2026 beat and the subsequent guidance increase make it obvious that it is participating materially in this wave.

Numbers that matter

Put simply: revenue momentum is real and accelerating, but valuation metrics are elevated. With free cash flow near $82.8 million against an $8.3B market cap, implied FCF yield is about 1% right now. EV/Sales of 5.5 and EV/EBITDA north of 36 imply the market is pricing sustained high-teens to twenty-something percent growth well into the forward period.

Technical & market structure context

Technically, the stock has pulled back from its 52-week high of $60.43 (04/30/2026) and sits below its 10-, 20- and 50-day moving averages. RSI is about 40, and MACD shows bearish momentum. Short interest has been meaningful but not excessive; the most recent settlement showed just under 10 million shares short with days-to-cover around 2.6, indicating the potential for squeezes but not a fragile short-squeeze setup.

Trade idea - tactical long (mid-term)

Action: go long VIAV at $33.67 (exact entry). Place a stop loss at $30.00. Target $45.00. Position sizing should reflect the elevated multiple and execution risk - treat this as a swing trade, not a buy-and-hold conviction.

• Horizon: mid term (45 trading days). This timeframe captures continued quarterly momentum, short-term order flow into data-center builds, and reaction to any incremental guidance updates.
• Why this entry: $33.67 reflects recent consolidation after the rapid re-rating. The stock has pulled back from the spring highs but still benefits from clear revenue acceleration; entry here balances momentum with a cushion should the pullback widen.
• Why the stop: $30.00 is below recent intraday support and keeps losses controlled if optical spending disappoints or broader risk-off hits cyclical tech names. It caps risk to roughly 11% from entry.
• Why the target: $45.00 is a pragmatic upside that recognizes both continued multiple expansion and revenue leverage from higher gross margins and operating leverage. It sits comfortably below the 52-week high but allows capture of another leg of the move if AI spending stays robust.

For traders who prefer shorter exposures: a short-term (10 trading days) objective would be to scalp to $36.50 on volume-led pops; conversely, long-term oriented investors willing to tolerate higher volatility could stretch the horizon to long term (180 trading days) and consider $60 if Viavi proves sustained revenue growth and margin expansion beyond current guidance.

Catalysts

• Continued AI data-center optical spend that keeps Network and Service Enablement growth above 30% year-over-year.
• Execution on integration and cross-sell opportunities with the Spirent acquisition and any other M&A that expands test & monitoring content per data-center deployment.
• Positive quarterly updates and guidance beats - the company guided Q1 to $450–460M revenue and non-GAAP EPS $0.40–0.42; further upside to this guidance would re-ignite the re-rating.
• Peer momentum among optical/network equipment names showing sustained demand (e.g., Ciena-like backlogs and orders) that validates a sector-wide re-rating.

Risks and counterarguments

Below are the primary risks that could derail this trade, followed by a counterargument to the base thesis.

• Deterioration in AI capex: Hyperscaler spending can be lumpy. A pause or delay in data-center expansions would quickly hit orders and revenue for Viavi, and the stock—priced for growth—would react sharply.
• Execution/margin risk: Fast revenue growth stresses supply chains and service delivery. If gross margins or operating leverage fail to scale with revenue, the multiple could compress even as top-line grows.
• Valuation compression: Current EV/Sales of ~5.5 and EV/EBITDA ~36 leave little room for disappointment. Even modest misses on revenue or EPS could produce outsized downside.
• Macro and rate volatility: Higher-for-longer interest rates or a risk-off move in tech could disproportionately punish high-multiple names like Viavi regardless of company fundamentals.
• Competitive risks: Large optical vendors and test-equipment incumbents could take share or push pricing pressure; integration of new technologies (optical or test automation) could alter win rates.

Counterargument: The bullish case is that current multiples reflect not optimism but realism: the market is rewarding clear, near-term secular revenue gains and durable share gains in a large TAM. If Viavi sustains 30%+ growth for several quarters and converts a meaningful portion of that revenue to cash flow, the present valuation would look justified—and the stock could re-test prior highs. That outcome depends on sustained hyperscaler orders and clean margin expansion, which is plausible given the company’s product footprint and recent execution.

What would change my mind

I am running this as a tactical, data-driven long because the revenue acceleration is verifiable and guidance is constructive. I will change my view to a higher-conviction long if two things happen: (1) Viavi delivers multiple consecutive quarters of revenue growth north of 30% with improving operating margins and materially higher free cash flow; and (2) management provides evidence of durable backlog that extends visibility beyond the next quarter. Conversely, a single quarter of miss versus guided revenue or EPS, or evidence of slowing hyperscaler commitments, would prompt me to tighten stops or flip to neutral/short depending on severity.

Bottom line: Viavi is an earnings/momentum story wrapped in a premium multiple. The trade is to participate on strength with a clear stop and defined target, because the upside is real but priced tightly to flawless execution.

Key points

• Q4 FY2026 revenue was $443.1M, up 52.5%, and adjusted EPS rose to $0.34 (08/27/2026 results).
• Guidance implies continued growth: Q1 revenue $450–460M; non-GAAP EPS $0.40–0.42.
• Valuation is full: market cap ~$8.3B, EV/Sales ~5.5, implied FCF yield roughly 1% on trailing free cash flow.
• Trade: long at $33.67, stop $30.00, target $45.00, mid term (45 trading days).